Search Within

Gopakumar Vasudeva Iyer

  1. "Early Drug Development Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
Groups
  1. Department of Medicine (25)
  2. Early Drug Development Service (25)
  3. Genitourinary Oncology Service (25)
  4. Solid Tumor Oncology Division (25)
  5. Gynecologic Medicine Service (18)
  6. Department of Pathology and Laboratory Medicine (17)

More Groups

People
  1. David Hyman (22)
  2. Michael Berger (14)
  3. David Solit (13)
  4. James Harding (8)
  5. Alexander Drilon (7)
  6. Alison Schram (7)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (3)
  6. 2017 (5)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Oncology (2)
  3. Cancer Research (2)
  4. Cancer (1)
  5. Clinical Advances in Hematology & Oncology (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (3)
  3. Nature Publishing Group (3)
  4. Oxford University Press (2)
  5. American Medical Association (1)
  6. Elsevier Inc. (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of extracellular signal-regulated kinase inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Canestraro, J.; Haggag-Lindgren, D.; Harding, J. J.; Diamond, E. L.; Drilon, A.; Li, B. T.; Iyer, G.; Schram, A. M.; Abramson, D. H.
    Ophthalmology Retina (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • Final results from the phase I study expansion cohort of the selective FGFR inhibitor Debio 1,347 in patients with solid tumors harboring an FGFR gene fusion
    Meeting Abstract

    Cleary, J. M.; Iyer, G.; Oh, D. Y.; Mellinghoff, I. K.; Goyal, L.; Ng, M. C. H.; Meric-Bernstam, F.; Matos, I.; Chao, T. Y.; Sarkouh, R. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of on-target adverse events caused by TRK inhibitor therapy
    Journal Article

    Liu, D.; Flory, J.; Lin, A.; Offin, M.; Falcon, C. J.; Murciano-Goroff, Y. R.; Rosen, E.; Guo, R.; Basu, E.; Li, B. T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Non-invasive detection of acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations
    Meeting Abstract

    Varghese, A. M.; Patel, J. A. A.; Janjigian, Y. Y.; Meng, F.; Selcuklu, S. D.; Zimel, C.; Hyman, D. M.; Iyer, G.; Houck-Loomis, B.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: Preliminary results
    Meeting Abstract

    Matos, I.; Goyal, L.; Cleary, J.; Voss, M.; Oh, D.; Bernstam, F. M.; Ng, C.; Iyer, G.; Ishii, N.; Hu, Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genome doubling shapes the evolution and prognosis of advanced cancers
    Journal Article

    Bielski, C. M.; Zehir, A.; Penson, A. V.; Donoghue, M. T. A.; Chatila, W.; Armenia, J.; Chang, M. T.; Schram, A. M.; Jonsson, P.; Bandlamudi, C.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • HER kinase inhibition in patients with HER2-and HER3-mutant cancers
    Journal Article

    Hyman, D. M.; Piha-Paul, S. A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G. I.; Juric, D.; Quinn, D. I.; Moreno, V.; Doger, B.; more...
    Nature (2018)

    Fulltext@MSK | Save